A detailed history of Bluefin Capital Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Bluefin Capital Management, LLC holds 9,700 shares of PFE stock, worth $271,406. This represents 0.02% of its overall portfolio holdings.

Number of Shares
9,700
Previous 9,700 -0.0%
Holding current value
$271,406
Previous $269,000 -0.0%
% of portfolio
0.02%
Previous 0.03%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$25.89 - $29.73 $251,133 - $288,381
9,700 New
9,700 $269,000
Q3 2023

Nov 14, 2023

BUY
$32.09 - $37.51 $346,572 - $405,108
10,800 New
10,800 $358,000
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $1.31 Million - $1.71 Million
-31,308 Reduced 48.87%
32,754 $1.68 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $782,516 - $955,256
17,882 Added 38.72%
64,062 $2.8 Million
Q2 2022

Aug 15, 2022

BUY
$46.53 - $55.17 $1.16 Million - $1.38 Million
24,980 Added 117.83%
46,180 $2.35 Million
Q1 2022

May 16, 2022

SELL
$45.75 - $56.69 $10.7 Million - $13.3 Million
-234,879 Reduced 91.72%
21,200 $1.1 Million
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $3.14 Million - $4.66 Million
76,021 Added 42.22%
256,079 $15.1 Million
Q3 2021

Nov 15, 2021

SELL
$39.25 - $50.42 $162,848 - $209,192
-4,149 Reduced 2.25%
180,058 $7.75 Million
Q2 2021

Aug 16, 2021

BUY
$35.91 - $40.68 $3.08 Million - $3.49 Million
85,770 Added 87.13%
184,207 $7.21 Million
Q1 2021

May 17, 2021

BUY
$33.49 - $37.77 $1.27 Million - $1.43 Million
37,800 Added 62.34%
98,437 $3.57 Million
Q4 2020

Feb 10, 2021

BUY
$33.47 - $42.56 $664,613 - $845,113
19,857 Added 48.69%
60,637 $2.23 Million
Q3 2020

Nov 16, 2020

BUY
$31.75 - $37.25 $1.29 Million - $1.52 Million
40,780 New
40,780 $1.5 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Bluefin Capital Management, LLC Portfolio

Follow Bluefin Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bluefin Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bluefin Capital Management, LLC with notifications on news.